NASDAQ : DRTS
Alpha Tau Medical Ltd. — Financial statements
Healthcare · Biotechnology · Israel
Last price 13.06 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.21B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 11.66M | 10.22M | 9.02M | 9.26M | 11.25M | 2.34M |
| Research & Development | 38.77M | 32.06M | 27.02M | 26.42M | 20.89M | 11.45M |
| Operating Expenses | 50.43M | 42.29M | 36.04M | 35.68M | 32.14M | 13.79M |
| Operating Income | -50.43M | -42.29M | -36.04M | -35.68M | -32.14M | -13.79M |
| Interest Expense | -360.00K | -347.00K | -303.00K | -75.00K | ||
| Interest & Investment Income | 3.88M | 3.84M | 4.28M | 4.83M | 1.79M | 211.00K |
| Currency Exchange Gain (Loss) | -1.67M | -1.62M | 106.00K | -210.00K | 413.00K | -412.00K |
| Other Non Operating Income (Expenses) | -43.81M | -2.09M | 218.00K | 1.99M | -3.81M | -13.27M |
| Pretax Income | -92.40M | -42.51M | -31.74M | -29.14M | -33.74M | -27.26M |
| Income Tax Expense | 175.00K | 121.00K | 6.00K | 16.00K | 20.00K | 7.00K |
| Earnings From Continuing Operations | -92.57M | -42.63M | -31.75M | -29.16M | -33.76M | -27.27M |
| Net Income | -92.57M | -42.63M | -31.75M | -29.16M | -33.76M | -27.27M |
| Net Income to Common | -92.57M | -42.63M | -31.75M | -29.16M | -33.76M | -27.27M |
| Shares Outstanding (Basic) | 88.02M | 80.58M | 69.93M | 69.38M | 63.53M | 40.53M |
| Shares Outstanding (Diluted) | 88.02M | 80.58M | 69.93M | 69.38M | 63.53M | 40.53M |
| EPS (Basic) | -1.05 | -0.53 | -0.45 | -0.42 | -0.53 | -0.67 |
| EPS (Diluted) | -1.05 | -0.53 | -0.45 | -0.42 | -0.53 | -0.67 |
| Free Cash Flow | -16.11M | -32.76M | -22.02M | -24.36M | -24.78M | -14.74M |
| Free Cash Flow Per Share | -0.18 | -0.41 | -0.32 | -0.35 | -0.39 | -0.36 |
| EBITDA | -48.76M | -41.06M | -34.94M | -34.61M | -31.16M | -13.01M |
| D&A For EBITDA | 1.67M | 1.23M | 1.10M | 1.07M | 979.00K | 776.00K |
| EBIT | -50.43M | -42.29M | -36.04M | -35.68M | -32.14M | -13.79M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 22.99M | 12.20M | 13.72M | 12.66M | 5.84M | 23.24M |
| Short-Term Investments | 77.65M | 60.92M | 45.88M | 69.13M | 98.69M | 8.08M |
| Cash & Short-Term Investments | 100.64M | 73.13M | 59.60M | 81.79M | 104.53M | 31.32M |
| Other Receivables | 336.00K | 332.00K | 344.00K | 313.00K | 480.00K | |
| Receivables | 336.00K | 332.00K | 344.00K | 313.00K | 480.00K | |
| Prepaid Expenses | 2.06M | 1.06M | 1.04M | 472.00K | 784.00K | 227.00K |
| Restricted Cash | 850.00K | 618.00K | ||||
| Other Current Assets | 4.13M | 3.78M | 3.25M | 3.15M | ||
| Total Current Assets | 106.83M | 78.30M | 64.23M | 85.76M | 106.48M | 32.64M |
| Property, Plant & Equipment | 26.89M | 26.88M | 21.54M | 21.16M | 13.28M | 7.55M |
| Other Long-Term Assets | 525.00K | 479.00K | 432.00K | 471.00K | 391.00K | 2.03M |
| Total Assets | 134.25M | 105.65M | 86.20M | 107.39M | 120.15M | 42.22M |
| Accounts Payable | 3.17M | 3.87M | 3.53M | 2.57M | 1.42M | 1.20M |
| Accrued Expenses | 5.15M | 5.51M | 4.13M | 3.40M | 2.18M | 3.15M |
| Current Portion of Leases | 1.32M | 1.13M | 1.01M | 1.06M | 669.00K | |
| Other Current Liabilities | 79.00K | 63.00K | 48.00K | |||
| Total Current Liabilities | 9.63M | 10.51M | 8.68M | 7.10M | 4.34M | 4.41M |
| Long-Term Debt | 6.80M | 6.35M | 5.56M | 5.61M | ||
| Long-Term Leases | 7.03M | 6.24M | 5.96M | 6.60M | 4.52M | |
| Long-Term Deferred Tax Liabilities | 312.00K | 97.00K | ||||
| Other Long-Term Liabilities | 47.54M | 5.35M | 3.34M | 3.60M | 5.63M | |
| Total Liabilities | 90.19M | 28.55M | 23.54M | 22.91M | 14.49M | 4.41M |
| Additional Paid-In Capital | 302.94M | 267.24M | 210.18M | 200.23M | 192.26M | 18.06M |
| Retained Earnings | -258.89M | -190.14M | -147.51M | -115.76M | -86.60M | -52.84M |
| Total Common Equity | 44.05M | 77.10M | 62.67M | 84.47M | 105.66M | -34.78M |
| Shareholders' Equity | 44.05M | 77.10M | 62.67M | 84.47M | 105.66M | 37.81M |
| Total Liabilities & Equity | 134.25M | 105.65M | 86.20M | 107.39M | 120.15M | 42.22M |
| Total Debt | 15.15M | 13.73M | 12.54M | 13.28M | 5.19M | |
| Net Cash (Debt) | 85.49M | 59.40M | 47.06M | 68.51M | 99.34M | 31.32M |
| Net Cash Per Share | 0.97 | 0.74 | 0.67 | 0.99 | 1.56 | 0.77 |
| Filing Date Shares Outstanding | 92.33M | 88.01M | 70.38M | 69.67M | 69.13M | 66.53M |
| Total Common Shares Outstanding | 92.33M | 88.01M | 70.38M | 69.67M | 69.11M | 40.53M |
| Working Capital | 97.20M | 67.79M | 55.55M | 78.65M | 102.14M | 28.24M |
| Book Value Per Share | 0.48 | 0.88 | 0.89 | 1.21 | 1.53 | -0.86 |
| Tangible Book Value | 44.05M | 77.10M | 62.67M | 84.47M | 105.66M | -34.78M |
| Tangible Book Value Per Share | 0.48 | 0.88 | 0.89 | 1.21 | 1.53 | -0.86 |
| Land | 5.25M | 5.25M | 5.25M | |||
| Machinery | 19.68M | 10.74M | 10.52M | 9.36M | 8.46M | |
| Construction In Progress | 2.00M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -92.57M | -42.63M | -31.75M | -29.16M | -33.76M | -27.27M |
| Depreciation & Amortization | 1.67M | 1.23M | 1.10M | 1.07M | 979.00K | 776.00K |
| Loss (Gain) From Sale of Assets | 35.00K | 35.00K | ||||
| Stock-Based Compensation | 11.99M | 10.62M | 9.92M | 7.93M | 6.75M | 812.00K |
| Other Operating Activities | 44.91M | 1.77M | -219.00K | -293.00K | 2.46M | 13.29M |
| Change in Accounts Payable | 768.00K | 337.00K | 965.00K | 1.14M | 220.00K | 239.00K |
| Change in Other Net Operating Assets | 1.36M | 1.86M | 203.00K | 1.35M | -527.00K | 346.00K |
| Operating Cash Flow | -12.81M | -26.68M | -19.78M | -17.96M | -23.88M | -11.81M |
| Capital Expenditures | -3.30M | -6.08M | -2.24M | -6.40M | -904.00K | -2.93M |
| Investment in Securities | -10.42M | -14.51M | 23.11M | 28.23M | -89.03M | 22.20M |
| Other Investing Activities | -48.00K | -103.00K | -3.15M | |||
| Investing Cash Flow | -13.77M | -20.59M | 20.77M | 18.68M | -89.94M | 19.27M |
| Short-Term Debt Issued | 5.15M | |||||
| Long-Term Debt Issued | 5.25M | |||||
| Total Debt Issued | 5.15M | 5.15M | 5.25M | |||
| Short-Term Debt Repaid | -5.15M | |||||
| Total Debt Repaid | -5.15M | -5.15M | ||||
| Net Debt Issued (Repaid) | 5.25M | |||||
| Issuance of Common Stock | 38.02M | 45.77M | 25.00K | 49.00K | 3.36M | 111.00K |
| Other Financing Activities | 93.54M | |||||
| Financing Cash Flow | 38.02M | 45.77M | 25.00K | 5.30M | 96.91M | 111.00K |
| Foreign Exchange Rate Adjustments | -148.00K | -21.00K | 57.00K | -50.00K | -258.00K | 108.00K |
| Net Cash Flow | 11.29M | -1.52M | 1.07M | 5.97M | -17.17M | 7.68M |
| Free Cash Flow | -16.11M | -32.76M | -22.02M | -24.36M | -24.78M | -14.74M |
| Free Cash Flow Per Share | -0.18 | -0.41 | -0.32 | -0.35 | -0.39 | -0.36 |
| Levered Free Cash Flow | -20.26M | -19.70M | -12.97M | -19.40M | -14.62M | -7.53M |
| Unlevered Free Cash Flow | -20.04M | -19.49M | -12.78M | -19.35M | -14.62M | -7.53M |
| Cash Interest Paid | 413.00K | 381.00K | 321.00K | 52.00K | ||
| Cash Income Tax Paid | 16.00K | 4.00K | 5.00K | 16.00K | 8.00K | 1.00K |
| Change in Working Capital | 21.16M | 2.29M | 1.17M | 2.49M | -307.00K | 585.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.21B | 422.06M | 217.32M | 209.12M | 219.46M | 337.56M |
| Enterprise Value | 1.12B | 363.35M | 164.66M | 127.95M | 111.79M | 350.88M |
| Last Close Price | 13.06 | 4.95 | 3.10 | 3.01 | 3.18 | 9.82 |
| PB Ratio | 27.37 | 5.47 | 3.47 | 2.48 | 2.08 | 8.93 |
| P/TBV Ratio | 27.37 | 5.47 | 3.47 | 2.48 | 2.08 | |
| Debt / Equity Ratio | 0.34 | 0.18 | 0.20 | 0.16 | 0.05 | |
| Net Debt / Equity Ratio | -1.94 | -0.77 | -0.75 | -0.81 | -0.94 | -0.83 |
| Net Debt / EBITDA Ratio | 1.75 | 1.45 | 1.35 | 1.98 | 3.19 | 2.41 |
| Net Debt / FCF Ratio | 5.30 | 1.81 | 2.14 | 2.81 | 4.01 | 2.12 |
| Quick Ratio | 10.45 | 6.99 | 6.91 | 11.56 | 24.17 | 7.22 |
| Current Ratio | 11.09 | 7.45 | 7.40 | 12.07 | 24.55 | 7.41 |
| Return on Equity (ROE) | -141.68% | -61.00% | -43.16% | -30.67% | -47.07% | -61.48% |
| Return on Assets (ROA) | -25.71% | -27.55% | -23.27% | -19.60% | -24.74% | -18.11% |
| Return on Capital Employed (ROCE) | -40.50% | -44.40% | -46.50% | -35.60% | -27.70% | -36.50% |
| Earnings Yield | -8.05% | -10.10% | -14.61% | -13.94% | -15.38% | -8.08% |
| FCF Yield | -1.34% | -7.76% | -10.13% | -11.65% | -11.29% | -4.37% |
| Buyback Yield / Dilution | -20.98% | -15.24% | -0.79% | -9.20% | -56.74% | -0.65% |